Department of Health and Social Care written question – answered on 13th November 2018.

Alert me about debates like this

Photo of Lord Wills Lord Wills Labour

To ask Her Majesty's Government what assessment they have made of the benefits to the NHS in England of early endovenous ablation of leg ulcers.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.

Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.